116 related articles for article (PubMed ID: 10927692)
1. Malignant melanoma and hormone replacement therapy.
Jeffery SL; Lewis JS
Br J Plast Surg; 2000 Sep; 53(6):539. PubMed ID: 10927692
[No Abstract] [Full Text] [Related]
2. [Pregnancy, hormone preparations and malignant melanoma].
Garbe C
Hautarzt; 1993 Jun; 44(6):347-52. PubMed ID: 8335457
[TBL] [Abstract][Full Text] [Related]
3. Controversial issues in climacteric medicine II. Hormone replacement therapy and cancer. International Menopause Society Expert Workshop. 9-12 June 2001, Opera del Duomo, Pisa, Italy.
Genazzani AR; Gadducci A; Gambacciani M
Climacteric; 2001 Sep; 4(3):181-93. PubMed ID: 11588941
[TBL] [Abstract][Full Text] [Related]
4. The risk of melanoma in association with long-term exposure to PUVA.
Stern RS;
J Am Acad Dermatol; 2001 May; 44(5):755-61. PubMed ID: 11312420
[TBL] [Abstract][Full Text] [Related]
5. Malignant melanoma during treatment with fumaric acid esters - coincidence or treatment-related?
Barth D; Simon JC; Wetzig T
J Dtsch Dermatol Ges; 2011 Mar; 9(3):223-5. PubMed ID: 20678147
[TBL] [Abstract][Full Text] [Related]
6. [Letter: Malignant melanoma during treatment with levodopa].
Pelfréne AF
Nouv Presse Med; 1975 May; 4(18):1365. PubMed ID: 1153302
[No Abstract] [Full Text] [Related]
7. Cutaneous complications of hormonal replacement therapy.
Mor Z; Caspi E
Clin Dermatol; 1997; 15(1):147-54. PubMed ID: 9034663
[No Abstract] [Full Text] [Related]
8. [Bladder cancer and malignant melanoma following Endoxan therapy of a lymphoproliferative disease].
Kaufmann B; Wegmann W
Schweiz Med Wochenschr; 1981 Apr; 111(15):540-5. PubMed ID: 7233132
[No Abstract] [Full Text] [Related]
9. [Hormone replacement therapy and breast cancer].
Mueck AO
Med Monatsschr Pharm; 2002 Oct; 25(10):337-47. PubMed ID: 12404946
[No Abstract] [Full Text] [Related]
10. Prenatal risk factors for cutaneous malignant melanoma: follow-up of 2,594,783 Danes born from 1950 to 2002.
Olesen AV; Parner ET; Mortensen PB; Sørensen HT; Olsen J
Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):155-61. PubMed ID: 19124493
[TBL] [Abstract][Full Text] [Related]
11. [Sun lotion and malignant malanoma].
Lock-Andersen J; Stender IM; Wulf HC
Ugeskr Laeger; 1995 Jun; 157(26):3778-9. PubMed ID: 7631460
[No Abstract] [Full Text] [Related]
12. Estrogen-progestogen replacement therapy and ovarian cancer: an update.
La Vecchia C
Eur J Cancer Prev; 2006 Dec; 15(6):490-2. PubMed ID: 17106327
[TBL] [Abstract][Full Text] [Related]
13. Chemical exposures other than arsenic are probably not important risk factors for squamous cell carcinoma, basal cell carcinoma and malignant melanoma of the skin.
Kennedy C; Bajdik CD; Willemze R; Bouwes Bavinck JN
Br J Dermatol; 2005 Jan; 152(1):194-7. PubMed ID: 15656837
[No Abstract] [Full Text] [Related]
14. Long-term use of estrogen-only hormone replacement therapy (HRT) linked with increased risk of ovarian cancer.
American Medical Association
Ginecol Obstet Mex; 2002 Aug; 70():409-10. PubMed ID: 12448047
[No Abstract] [Full Text] [Related]
15. [Treatment of sterility and melanoma].
Schmutz JL; Barbaud A; Trechot P
Ann Dermatol Venereol; 2002 Oct; 129(10 Pt 1):1211. PubMed ID: 12442144
[No Abstract] [Full Text] [Related]
16. [Melanoma during latanoprost therapy: three cases].
Estève E; Beau-Salinas F; Estève L; Lemacon JM; Autret-Leca E; Le Louet H; Hocine R; Wolkenstein P; Plaquet JL
Ann Dermatol Venereol; 2009 Jan; 136(1):60-1. PubMed ID: 19171236
[No Abstract] [Full Text] [Related]
17. The association between residential pesticide use and cutaneous melanoma.
Fortes C; Mastroeni S; Melchi F; Pilla MA; Alotto M; Antonelli G; Camaione D; Bolli S; Luchetti E; Pasquini P
Eur J Cancer; 2007 Apr; 43(6):1066-75. PubMed ID: 17331713
[TBL] [Abstract][Full Text] [Related]
18. [Postmenopausal hormone replacement therapy--is there a cause of worry?].
Skouby SO; Wilken-Jensen C; Jespersen J; Pedersen AT; Ottesen BS
Ugeskr Laeger; 2002 Aug; 164(34):3974-5. PubMed ID: 12212482
[No Abstract] [Full Text] [Related]
19. Does the decrease in hormone replacement therapy also affect breast cancer risk in the Netherlands?
Soerjomataram I; Coebergh JW; Louwman MW; Visser O; van Leeuwen FE
J Clin Oncol; 2007 Nov; 25(31):5038-9; author reply 5039-40. PubMed ID: 17971608
[No Abstract] [Full Text] [Related]
20. Postmenopausal exogenous hormone therapy and Melanoma risk in women: A systematic review and time-response meta-analysis.
Tang X; Zhang H; Cui Y; Wang L; Wang Z; Zhang Y; Huo J; Cai J; Rinaldi G; Bhagavathula AS; Xiaopeng Y
Pharmacol Res; 2020 Oct; 160():105182. PubMed ID: 32890740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
